A Harvard University expert has issued a cautionary note for individuals with allergies, advising them to consider alternatives to antihistamines. This warning comes in the wake of research suggesting a potential link between these popular medications and an increased risk of dementia.

Writing on the prestigious university’s website, a leading physician highlighted studies indicating that over-the-counter antihistamine pills could interfere with a protective chemical in the brain, potentially increasing the risk of dementia. Dr. Anthony L. Komaroff, an experienced family doctor and editor in chief of the Harvard Health Letter, emphasized that while the risk is still theoretical, it has prompted him to rethink his approach to taking these drugs.

‘I weigh the symptom relief they give me against the possibility that they may slightly increase my risk of developing dementia,’ he wrote.

‘I ask if there are other drugs that might also give me symptom relief, without the theoretical risk of cognitive decline. I also use the lowest possible dose to get symptom relief.’

Dr. Anthony L. Komaroff

This warning is particularly timely as the U.S. enters its annual hay fever season, which typically begins in late March and extends through September. Approximately one in four Americans—about 81 million people—suffer from hay fever and many turn to antihistamines for relief.

Dr. Komaroff explained that the theoretical risk posed by antihistamines is linked to their mechanism of action. These drugs, known as anticholinergics, interfere with the brain’s release of a vital chemical called acetylcholine. While this effectively limits allergic symptoms, low levels of acetylcholine are associated with an increased risk of dementia.

Dr. Komaroff elaborated, ‘Theoretically, these drugs might increase the risk of dementia by blocking a particular brain neurotransmitter [brain chemical] or increasing brain inflammation.’ However, he cautioned that the science behind this theory is not yet settled.

Over the past decade, several studies have explored this potential link. A 2015 study tracked the brain health of more than 3,400 participants over 65 years old between 1994 and 2012. Researchers found a correlation between increased doses of anticholinergics and the development of dementia. A separate 2024 study published in the Journal of Allergy and Clinical Immunology also revealed a link between antihistamines and dementia.

Researchers conducted a retrospective cohort study using data from Taiwan’s National Health Insurance Research Database from 2011 to 2017. The study included more than 700,000 patients with recent-onset allergic hay fever, split into groups based on whether they took antihistamines or not. After adjusting for preexisting medical conditions, the researchers found a dose-dependent increase in dementia risk.

Hay fever drugs are not the only anticholinergic medications commonly used. Other examples include some sleep medications, treatments for urinary incontinence, nausea, muscle tension, and Parkinson’s disease. In December, a British study on more than a million people found that taking anticholinergics was linked to an 18 percent increased risk of dementia diagnosis. Men were slightly more vulnerable, with an increased risk of 22 percent, compared to 16 percent for women.

Dementia has a variety of causes, two of the most common being Alzheimer’s disease and vascular dementia, which results from reduced blood flow to the brain following a stroke. Recent analysis by the Alzheimer’s Society estimated the overall annual cost of dementia in the UK is £42 billion a year, with families bearing the brunt. An aging population means these costs—which include lost earnings of unpaid carers—are set to soar to £90 billion in the next 15 years. Around 944,000 in the UK are thought to be living with dementia while the figure is thought to be around 7 million in the U.S.

Memory problems, thinking and reasoning difficulties, and language problems are common early symptoms of the condition, which then worsen over time. A separate Alzheimer’s Research UK analysis found 74,261 people died from dementia in 2022 compared with 69,178 a year earlier, making it the country’s biggest killer.

Despite these findings, it is essential to note that the research is not conclusive. Some studies have found no risk, and all studies have inherent flaws. Therefore, while the potential risk is concerning, it is not definitive. Individuals should consult with their healthcare providers to weigh the benefits and risks of antihistamines, especially if they have other risk factors for dementia.

For those seeking alternatives to antihistamines, there are several options. Nasal corticosteroids, such as fluticasone or mometasone, can be effective in managing hay fever symptoms without the same theoretical risks. Allergy shots, or immunotherapy, can also provide long-term relief by desensitizing the immune system to allergens. Additionally, lifestyle changes such as avoiding allergens, using air purifiers, and maintaining a healthy diet can help manage symptoms.

In conclusion, while the potential link between antihistamines and dementia is a cause for concern, it is not a definitive risk. Individuals should be aware of the potential risks and consult with their healthcare providers to make informed decisions about their treatment options. As research continues, it is crucial to stay informed and consider all available evidence when managing allergies and dementia risk.

What is the potential link between antihistamines and dementia?

Research has suggested a potential link between antihistamines and an increased risk of dementia. Antihistamines, such as those used for allergies, are anticholinergics that interfere with the brain’s release of acetylcholine, a chemical linked to cognitive function. There’s concern that their usage could increase dementia risk, although the evidence is not yet conclusive [1].

Why should individuals with allergies be cautious about using antihistamines?

Dr. Anthony L. Komaroff, a Harvard expert, has cautioned individuals with allergies about using antihistamines due to their potential to increase dementia risk.With the onset of hay fever season, many rely on these medications for relief, but Dr. Komaroff advocates for weighing symptom relief against the theoretical cognitive risks. He suggests considering choice treatments and using the lowest effective dose [2].

What mechanism might make antihistamines a dementia risk?

The theoretical risk involves antihistamines’ anticholinergic action, which blocks acetylcholine—a neurotransmitter essential to learning and memory. Low levels of acetylcholine have been associated with dementia risk.the drugs might also increase brain inflammation, a factor in cognitive decline. Though, the science is not yet settled, and some studies have found no significant risk [3].

What does the evidence suggest about anticholinergics and dementia?

• A 2015 study showed a correlation between increased doses of anticholinergics and dementia progress among participants over 65.
• A 2024 study published in the Journal of Allergy and Clinical Immunology indicated a link between antihistamines and dementia.
• A retrospective cohort study in Taiwan associated increased doses of antihistamines with a higher dementia risk, after adjusting for other conditions [3].
• A UK study found that using anticholinergics increased the dementia diagnosis risk by 18%, with men slightly more affected than women.

Are all antihistamines and anticholinergics equally risky?

Not all antihistamines and anticholinergic drugs carry the same level of risk. The strength and cumulative dosage appear to play a critical role. Studies indicate that higher doses and long-term use considerably increase dementia risk. It’s crucial to consult healthcare providers about dosing and alternatives [1].

What are some alternatives to antihistamines for allergy relief?

For those concerned about the potential risks associated with antihistamines, several alternatives may be considered, such as:

1. Nasal corticosteroids: Medications like fluticasone or mometasone can relieve symptoms without significant cognitive risks.
2. Allergy shots (immunotherapy): These can provide long-term relief by desensitizing the immune system to allergens.
3. Lifestyle changes: Avoiding allergens, using air purifiers, and maintaining a healthy diet can help manage symptoms.

Why is it significant to consult healthcare providers regarding antihistamine use?

While the potential risk of dementia from antihistamines is concerning, it is not definitive. Healthcare providers can help individuals assess the balance between benefits and risks, considering personal health factors. They can recommend suitable alternatives and dosages, ensuring effective symptom management with minimal risk [2].

How should individuals approach managing allergies given the potential dementia risk?

Individuals should stay informed about current research and consult with healthcare providers to explore the safest and most effective treatment options. It’s crucial to balance allergy management with long-term cognitive health, adapting strategies over time as research evolves. Adopting alternative therapies and lifestyle adjustments can also play a role in reducing reliance on antihistamines [3].

Summary and Final Thoughts

The potential link between antihistamines and dementia is an area of active research, with significant implications for public health. While some studies suggest a connection, the evidence is not yet conclusive, and more research is needed. Individuals should be proactive in managing allergies by consulting healthcare providers and considering a range of safe treatment options. Staying informed and aware of the latest findings will allow for better-aligned health strategies with possible future findings.